Artículos por temáticas

Balance and mobility in patients with newly diagnosed Parkinson's disease - a five-year follow-up of a cohort in northern Sweden.

Johansson C, Lindström B, Forsgren L, Johansson GM.

Disabil Rehabil. 2020 Mar;42(6):770-778. doi: 10.1080/09638288.2018.1509240. Epub 2018 Nov 19.

Executive function but not episodic memory decline associated with visual hallucinations in Parkinson's disease.

Creese B, Albertyn CP, Dworkin S, Thomas RS, Wan YM, Ballard C.

J Neuropsychol. 2020 Mar;14(1):85-97. doi: 10.1111/jnp.12169. Epub 2018 Jul 23.

A Survey of Application of Complementary and Alternative Medicine in Chinese Patients with Parkinson's Disease: A Pilot Study.

Pan XW, Zhang XG, Chen XC, Lu Q, Hu YS, Han LY, Zheng JL, Jin J, Zheng GQ.

Chin J Integr Med. 2020 Mar;26(3):168-173. doi: 10.1007/s11655-018-2560-y. Epub 2018 Jun 18.

A sticky situation: Aberrant protein-protein interactions in Parkinson's disease.

Brown J, Horrocks MH.

Semin Cell Dev Biol. 2020 Mar;99:65-77. doi: 10.1016/j.semcdb.2018.05.006. Epub 2018 May 10. Review.

Bioluminescence-driven optogenetic activation of transplanted neural precursor cells improves motor deficits in a Parkinson's disease mouse model.

Zenchak JR, Palmateer B, Dorka N, Brown TM, Wagner LM, Medendorp WE, Petersen ED, Prakash M, Hochgeschwender U.

J Neurosci Res. 2020 Mar;98(3):458-468. doi: 10.1002/jnr.24237. Epub 2018 Mar 25.

Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.

Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, Green SJ, Naqib A, Roy A, Kordower JH, Pahan K, Shannon KM, Keshavarzian A.

Neurobiol Dis. 2020 Feb;135:104352. doi: 10.1016/j.nbd.2018.12.012. Epub 2018 Dec 21. Review.

Neuropsychiatric complications and neuroimaging characteristics after deep brain stimulation surgery for Parkinson's disease.

Radziunas A, Deltuva VP, Tamasauskas A, Gleizniene R, Pranckeviciene A, Surkiene D, Bunevicius A.

Brain Imaging Behav. 2020 Feb;14(1):62-71. doi: 10.1007/s11682-018-9971-4.

Short-afferent inhibition and cognitive impairment in Parkinson's disease: A quantitative review and challenges.

Martin-Rodriguez JF, Mir P.

Neurosci Lett. 2020 Feb 6;719:133679. doi: 10.1016/j.neulet.2018.06.048. Epub 2018 Jun 28. Review.

Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognitive impairment.

Shepherd TA, Edelstyn NMJ, Longshaw L, Sim J, Watts K, Mayes AR, Murray M, Ellis SJ.

Pilot Feasibility Stud. 2017 Jul 6;4:11. doi: 10.1186/s40814-017-0154-7. eCollection 2018.

Parkinson's disease prevalence in Fabry disease: A survey study.

Wise AH, Yang A, Naik H, Stauffer C, Zeid N, Liong C, Balwani M, Desnick RJ, Alcalay RN.

Mol Genet Metab Rep. 2017 Nov 9;14:27-30. doi: 10.1016/j.ymgmr.2017.10.013. eCollection 2018 Mar.

The pathophysiological mechanisms of motivational deficits in Parkinson's disease.

Chagraoui A, Boukhzar L, Thibaut F, Anouar Y, Maltête D.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:138-152. doi: 10.1016/j.pnpbp.2017.10.022. Epub 2017 Oct 31. Review.

MTHFR C677T and A1298C polymorphisms may contribute to the risk of Parkinson's disease: A meta-analysis of 19 studies.

Liu L, Zhang L, Guo L, Yu Q, Li H, Teng J, Xie A.

Neurosci Lett. 2018 Jan 1;662:339-345. doi: 10.1016/j.neulet.2017.10.060. Epub 2017 Oct 31.

Evaluating psychiatric symptoms in Parkinson's Disease by a clinimetric analysis of the Hopkins Symptom Checklist (SCL-90-R).

Carrozzino D, Morberg BM, Siri C, Pezzoli G, Bech P.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:131-137. doi: 10.1016/j.pnpbp.2017.10.024. Epub 2017 Nov 1.

Sleep disorders and Parkinson disease; lessons from genetics.

Gan-Or Z, Alcalay RN, Rouleau GA, Postuma RB.

Sleep Med Rev. 2018 Jan 31. pii: S1087-0792(18)30007-8. doi: 10.1016/j.smrv.2018.01.006. [Epub ahead of print] Review.

Effects of Transcranial Direct Current Stimulation Plus Physical Therapy on Gait in Patients With Parkinson Disease: A Randomized Controlled Trial.

Yotnuengnit P, Bhidayasiri R, Donkhan R, Chaluaysrimuang J, Piravej K.

Am J Phys Med Rehabil. 2018 Jan;97(1):7-15. doi: 10.1097/PHM.0000000000000783.